Ociperlimab: The Hopeful Method in Immune-Mediated Condition
Ociperlimab represents a significant advance in addressing self-immune disorders. Its investigational antibody treatment blocks neonatal Fc receptor gamma , a molecule involved in promoting immune responses. Initial clinical data indicate promise for diminishing severity across various conditions